nisoldipine has been researched along with Cardiac Remodeling, Ventricular in 4 studies
Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with nisoldipine had no influence on LV volumes in either of the two groups or in the total study group." | 6.69 | Left ventricular remodelling in post-myocardial infarction patients with left ventricular ejection fraction 40-50% vs 25-39%. Influence of nisoldipine treatment? An echocardiographic substudy from the DEFIANT II study. ( Kirwan, B; Lubsen, K; Otterstad, JE; Parker, A; Plappert, T; St John Sutton, MG, 1999) |
| "Treatment with nisoldipine had no influence on LV volumes in either of the two groups or in the total study group." | 2.69 | Left ventricular remodelling in post-myocardial infarction patients with left ventricular ejection fraction 40-50% vs 25-39%. Influence of nisoldipine treatment? An echocardiographic substudy from the DEFIANT II study. ( Kirwan, B; Lubsen, K; Otterstad, JE; Parker, A; Plappert, T; St John Sutton, MG, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Otterstad, JE | 1 |
| Lubsen, K | 1 |
| Parker, A | 1 |
| Kirwan, B | 1 |
| Plappert, T | 1 |
| St John Sutton, MG | 1 |
| Barth, W | 1 |
| Deten, A | 2 |
| Bauer, M | 1 |
| Reinohs, M | 1 |
| Leicht, M | 2 |
| Zimmer, HG | 2 |
| Huang, B | 1 |
| Qin, D | 1 |
| Deng, L | 1 |
| Boutjdir, M | 1 |
| E1-Sherif, N | 1 |
| Briest, W | 1 |
| Hölzl, A | 1 |
| Rassler, B | 1 |
| Baba, HA | 1 |
1 trial available for nisoldipine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Left ventricular remodelling in post-myocardial infarction patients with left ventricular ejection fraction 40-50% vs 25-39%. Influence of nisoldipine treatment? An echocardiographic substudy from the DEFIANT II study.
Topics: Adult; Aged; Calcium Channel Blockers; Double-Blind Method; Echocardiography; Female; Follow-Up Stud | 1999 |
3 other studies available for nisoldipine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Differential remodeling of the left and right heart after norepinephrine treatment in rats: studies on cytokines and collagen.
Topics: Adrenergic Antagonists; Animals; Atrial Natriuretic Factor; Calcium Channel Blockers; Carbazoles; Ca | 2000 |
Reexpression of T-type Ca2+ channel gene and current in post-infarction remodeled rat left ventricle.
Topics: Analysis of Variance; Animals; Animals, Newborn; Calcium Channel Blockers; Calcium Channels, T-Type; | 2000 |
Cardiac remodeling after long term norepinephrine treatment in rats.
Topics: Adrenergic Antagonists; Analysis of Variance; Animals; Blotting, Western; Calcium Channel Blockers; | 2001 |